Perspective Therapeutics, Inc.
CATX
Revenue
2.19M
▲97.00k▲4.65%
3 Months ChangeAssets
385.92M
▲107.63M▲38.68%
3 Months ChangeLiabilities
44.92M
▼-3.47M▼-7.18%
3 Months ChangeFree Cash Flow
4.78M
▲14.70M▲148.13%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-11
Form 8-K
ID: 0001193125-24-236468
2024-09-20
Form 8-K
ID: 0000950170-24-108407
2024-09-05
Form 8-K
ID: 0000950170-24-103731
2024-08-30
Form 8-K
ID: 0000950170-24-102338
2024-08-19
Form 8-K
ID: 0000950170-24-098685
2024-08-13
Form 8-K
ID: 0000950170-24-096433
2024-08-13
Form 10-Q
ID: 0000950170-24-096148
2024-08-13
Form 8-K
ID: 0000950170-24-095707
2024-08-12
Form 8-K
ID: 0000950170-24-095411
2024-06-14
Form 8-K
ID: 0000950170-24-073631